D-0794-2022 Class II Terminated

Recalled by Teva Pharmaceuticals USA Inc — Parsippany, NJ

Recall Details

Product Type
Drugs
Report Date
May 4, 2022
Initiation Date
April 15, 2022
Termination Date
May 25, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
353964 units

Product Description

Lidocaine 2.5% and Prilocaine 2.5% Cream, USP, packaged in a) 5 g tubes (NDC 0591-2070-72), b) 30 g tubes (NDC 0591-2070-30), Rx Only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310, USA, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, USA

Reason for Recall

cGMP Deviations

Distribution Pattern

Nationwide within the United States

Code Information

Lot #: a) 16291, Exp. Date 01/2024;16469, Exp. Date 02/2024; b)16255, Exp. Date 11/2022; 16256, 16412 Exp. Date 02/2024; 16257, 16258, Exp. Date12/2022; 16505, 6506, Exp. Date 03/2024; 16627,16786, 16787,16820, Exp. Date 04/2024.